Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Filings indexed 570 across all filing types
Latest filing 2016-07-13 Regulatory Filings
Country FR France
Listing PA ALCAR

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific operational milestone: CARMAT obtaining necessary authorizations (CPP and ANSM) to start the PIVOT study in France for its artificial heart. This is a time-sensitive, material announcement regarding regulatory progress and clinical trials, but it is not a full financial report (like 10-K or IR), a transcript (CT), or a formal dividend/share change notice. It is a general corporate update concerning regulatory/clinical progress. Since it is a press release announcing a significant event rather than a formal regulatory filing like a 10-K or a specific financial report, it fits best under the general category for regulatory announcements or significant corporate news that doesn't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the best general category for non-standard, material announcements, although 'LTR' (Legal Proceedings Report) is related to regulatory bodies, this is an approval, not a legal proceeding. 'RNS' is the most appropriate fallback for a press release detailing regulatory/clinical progress.
2016-07-13 French
Document availability communications / Preparatory documents for the general meeting
AGM Information Classification · 1% confidence The document is explicitly titled 'Extraordinary General Meeting of August 10, 2016 Notice of the Meeting' and informs shareholders about the date, time, and location of an EGM. The primary purpose discussed is authorizing a bonus share plan. This content directly relates to materials shared for a shareholder meeting, fitting the definition of AGM Information (AGM-R), even though it is an EGM, as AGM-R is the closest category for general meeting materials. It is a notice/announcement about the meeting, not the voting results (DVA) or proxy materials (PSI).
2016-07-07 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces the convocation of an "Assemblée Générale Extraordinaire" (Extraordinary General Meeting - EGM) scheduled for August 10, 2016. The primary purpose of this EGM is to authorize a free share plan linked to performance criteria. This document is an official notice calling for a shareholder meeting and detailing the main resolution to be voted upon. This strongly aligns with the purpose of a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it is a notice, the content is substantive regarding a key corporate action requiring shareholder approval, making PSI more specific than a general RPA or RNS. It is not the voting results (DVA), nor is it the full AGM presentation (AGM-R).
2016-07-07 French
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific corporate action: CARMAT beginning the CE certification process for its artificial heart with DEKRA. It details strategic steps, management commentary, and future outlook, characteristic of a public announcement intended for immediate dissemination to the market and investors. It is not a comprehensive annual report (10-K), a quarterly report (IR), a transcript (CT), or a formal regulatory filing like a DVA or DIRS. Since it is a general, time-sensitive corporate announcement that doesn't fit the highly specific categories like DIV, CAP, or MANG, it falls best under the general Regulatory Filings/Announcements category (RNS), as it is a formal communication to the market about a significant operational milestone, although it could also be argued as a general announcement not covered elsewhere. Given the options, RNS serves as the best fit for a general press release announcing operational progress that isn't a financial result release (ER) or a specific transaction/governance event.
2016-06-23 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces that CARMAT is engaging in certification procedures with DEKRA for the CE marking of its artificial heart. This is a specific operational update regarding regulatory compliance and product development, not a comprehensive financial report (like 10-K or IR), a formal earnings announcement (ER), or a transcript (CT). It details a significant step towards commercialization. Since it is a specific announcement about a regulatory/development milestone that doesn't fit the other specific categories (like M&A, Dividend, Director Dealing), it falls best under the general category for regulatory announcements or significant corporate news that isn't strictly financial reporting. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a press release detailing a major regulatory/certification step, although it could also be argued as a general corporate update. However, RNS is defined as 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories.' This fits well as a non-standard regulatory/operational announcement.
2016-06-23 French
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
Report Publication Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and is dated June 7, 2016. The primary purpose of the text is to inform shareholders and the financial community that the preparatory documents for the upcoming Annual General Meeting (AGM) scheduled for June 28, 2016, are available for consultation or request. Since the document is an announcement about the availability of AGM materials rather than the AGM materials themselves or the voting results, it fits the description of a Report Publication Announcement (RPA) or potentially a general Regulatory Filing (RNS). Given the specific mention of documents being made available for an 'assemblée générale' (General Meeting), RPA is a strong candidate, as it signals the publication of related materials. However, since the core content is an announcement regarding the availability of documents for an AGM, and it is a short press release format, classifying it as a Report Publication Announcement (RPA) is appropriate, as it announces the publication/availability of other reports/materials. If the content were the actual AGM presentation, it would be AGM-R. If it were the voting results, it would be DVA. Since it's an announcement about the availability of AGM documents, RPA is the best fit based on Rule 2 (Menu vs Meal).
2016-06-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.